Literature DB >> 20736926

A changing perspective: improving access to fertility preservation.

Joseph M Letourneau1, Michelle E Melisko, Marcelle I Cedars, Mitchell P Rosen.   

Abstract

Approximately 120,000 young women are diagnosed with cancer every year in the USA. Many will have treatment that can reduce their fertility, although few will learn this fact before their treatment commences. This presents a tremendous quality of life issue post-treatment, as evidenced in this Perspectives by a personal account from a 23-year-old woman diagnosed with breast cancer. Clinicians must increase awareness about patients' desires for motherhood and awareness about their individual reproductive potential. We demonstrate novel evidence about the wide variability in ovarian reserve in women of similar age, using assessment by antral follicle count. We show how a unified approach between oncology and fertility teams can help patients better understand their risk of treatment-related infertility, as well as how to take effective measures to mitigate it. Finally, we present options for fertility preservation, based on the time point at which consultation occurs.

Entities:  

Mesh:

Year:  2010        PMID: 20736926      PMCID: PMC3226819          DOI: 10.1038/nrclinonc.2010.133

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   66.675


  37 in total

1.  Assessment of ovarian reserve in adult childhood cancer survivors using anti-Müllerian hormone.

Authors:  S Lie Fong; J S E Laven; F G A J Hakvoort-Cammel; I Schipper; J A Visser; A P N Themmen; F H de Jong; M M van den Heuvel-Eibrink
Journal:  Hum Reprod       Date:  2009-01-18       Impact factor: 6.918

Review 2.  Symptom management in premenopausal patients with breast cancer.

Authors:  Charles L Loprinzi; Sherry L Wolf; Debra L Barton; Nadia Ni Laack
Journal:  Lancet Oncol       Date:  2008-10       Impact factor: 41.316

3.  Egg retrieval with cryopreservation does not delay breast cancer treatment.

Authors:  Andrea Madrigrano; Lynn Westphal; Irene Wapnir
Journal:  Am J Surg       Date:  2007-10       Impact factor: 2.565

4.  Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study.

Authors:  Ahmed Badawy; Aboubakr Elnashar; Mohamed El-Ashry; May Shahat
Journal:  Fertil Steril       Date:  2008-08-03       Impact factor: 7.329

5.  Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study.

Authors:  Amr A Azim; Maria Costantini-Ferrando; Kutluk Oktay
Journal:  J Clin Oncol       Date:  2008-06-01       Impact factor: 44.544

Review 6.  Present and future fertility preservation strategies for female cancer patients.

Authors:  Elena S Georgescu; Jeffrey M Goldberg; Stefan S du Plessis; Ashok Agarwal
Journal:  Obstet Gynecol Surv       Date:  2008-11       Impact factor: 2.347

7.  A new model of reproductive aging: the decline in ovarian non-growing follicle number from birth to menopause.

Authors:  Karl R Hansen; Nicholas S Knowlton; Angela C Thyer; Jay S Charleston; Michael R Soules; Nancy A Klein
Journal:  Hum Reprod       Date:  2008-01-11       Impact factor: 6.918

8.  A pilot study of predictive markers of chemotherapy-related amenorrhea among premenopausal women with early stage breast cancer.

Authors:  Carey Anders; P Kelly Marcom; Bercedis Peterson; Lin Gu; Sue Unruhe; Renee Welch; Peggy Lyons; Millie Behera; Susannah Copland; Gretchen Kimmick; Heather Shaw; Stacey Snyder; Monica Antenos; Teresa Woodruff; Kimberly Blackwell
Journal:  Cancer Invest       Date:  2008 Apr-May       Impact factor: 2.176

9.  Letrozole for ovulation induction and fertility preservation by embryo cryopreservation in young women with endometrial carcinoma.

Authors:  Amr Azim; Kutluk Oktay
Journal:  Fertil Steril       Date:  2007-04-10       Impact factor: 7.329

Review 10.  Clinical practice. Primary ovarian insufficiency.

Authors:  Lawrence M Nelson
Journal:  N Engl J Med       Date:  2009-02-05       Impact factor: 91.245

View more
  16 in total

1.  Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer.

Authors:  Joseph M Letourneau; Erin E Ebbel; Patricia P Katz; Audra Katz; Wei Z Ai; A Jo Chien; Michelle E Melisko; Marcelle I Cedars; Mitchell P Rosen
Journal:  Cancer       Date:  2011-09-01       Impact factor: 6.860

2.  Long-term hormonal contraceptive use is associated with a reversible suppression of antral follicle count and a break from hormonal contraception may improve oocyte yield.

Authors:  Joseph M Letourneau; Hakan Cakmak; Molly Quinn; Nikita Sinha; Marcelle I Cedars; Mitchell P Rosen
Journal:  J Assist Reprod Genet       Date:  2017-07-01       Impact factor: 3.412

3.  Oncofertility in Canada: an overview of Canadian practice and suggested action plan.

Authors:  R Ronn; H E G Holzer
Journal:  Curr Oncol       Date:  2013-10       Impact factor: 3.677

4.  Acute ovarian failure underestimates age-specific reproductive impairment for young women undergoing chemotherapy for cancer.

Authors:  Joseph M Letourneau; Erin E Ebbel; Patricia P Katz; Kutluk H Oktay; Charles E McCulloch; Wei Z Ai; A Jo Chien; Michelle E Melisko; Marcelle I Cedars; Mitchell P Rosen
Journal:  Cancer       Date:  2011-08-17       Impact factor: 6.860

Review 5.  Breast cancer under age 40: a different approach.

Authors:  D Ribnikar; J M Ribeiro; D Pinto; B Sousa; A C Pinto; E Gomes; E C Moser; M J Cardoso; F Cardoso
Journal:  Curr Treat Options Oncol       Date:  2015-04

6.  Patient perceptions of reproductive health counseling at the time of cancer diagnosis: a qualitative study of female California cancer survivors.

Authors:  Erin Ebbel Niemasik; Joseph Letourneau; Daniel Dohan; Audra Katz; Michelle Melisko; Hope Rugo; Mitchell Rosen
Journal:  J Cancer Surviv       Date:  2012-07-03       Impact factor: 4.442

7.  Oncofertility in Canada: cryopreservation and alternative options for future parenthood.

Authors:  R Ronn; H E G Holzer
Journal:  Curr Oncol       Date:  2014-02       Impact factor: 3.677

8.  Assessing the Reproductive Concerns of Children and Adolescents with Cancer: Challenges and Potential Solutions.

Authors:  Caprice A Knapp; Gwendolyn P Quinn; Devin Murphy
Journal:  J Adolesc Young Adult Oncol       Date:  2011-04       Impact factor: 2.223

9.  Factors associated with the receipt of fertility preservation services along the decision-making pathway in young Canadian female cancer patients.

Authors:  Samantha Yee
Journal:  J Assist Reprod Genet       Date:  2015-11-11       Impact factor: 3.412

10.  Deliveries following fertility preservation by ovarian tissue cryopreservation without autotransplantation-what should be expected?

Authors:  Daniel Lantsberg; Adel Farhi; Inna Zaslavsky-Paltiel; Barbara G Silverman; Liat Lerner-Geva; Raoul Orvieto
Journal:  J Assist Reprod Genet       Date:  2018-10-29       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.